Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug

被引:59
|
作者
Carlyle, Wenda C. [1 ]
McClain, James B. [1 ]
Tzafriri, Abraham R. [2 ,3 ]
Bailey, Lynn [2 ]
Zani, Brett G. [2 ]
Markham, Peter M. [2 ]
Stanley, James R. L. [2 ]
Edelman, Elazer R. [3 ]
机构
[1] Micell Technol Inc, Durham, NC 27713 USA
[2] CBSET Inc, Concord Biomed Sci & Emerging Technol, Lexington, MA 02421 USA
[3] MIT, Cambridge, MA 02139 USA
关键词
Stent; PLGA; Crystalline; Sirolimus; Modeling; Pharmacokinetic; ELUTING STENT; RELEASE; DEPOSITION; SIROLIMUS; ARTERIAL;
D O I
10.1016/j.jconrel.2012.07.004
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Current drug eluting stent (DES) technology is not optimized with regard to the pharmacokinetics of drug delivery. A novel, absorbable-coating sirolimus-eluting stent (AC-SES) was evaluated for its capacity to deliver drug more evenly within the intimal area rather than concentrating drug around the stent struts and for its ability to match coating erosion with drug release. The coating consisted of absorbable poly-lactide-co-glycolic acid (PLGA) and crystalline sirolimus deposited by a dry-powder electrostatic process. The AC-SES demonstrated enhanced drug stability under simulated use conditions and consistent drug delivery balanced with coating erosion in a porcine coronary implant model. The initial drug burst was eliminated and drug release was sustained after implantation. The coating was absorbed within 90 days. Following implantation into porcine coronary arteries the AC-SES coating is distributed in the surrounding intimal tissue over the course of several weeks. Computational modeling of drug delivery characteristics demonstrates how distributed coating optimizes the load of drug immediately around each stent strut and extends drug delivery between stent struts. The result was a highly efficient arterial uptake of drug with superior performance to a clinical bare metal stent (BMS). Neointimal thickness (0.17+/-0.07 mm vs. 0.28+/-0.11 mm) and area percent stenosis (22+/-9% vs. 35+/-12%) were significantly reduced (p<0.05) by the AC-SES compared to the BMS 30 days after stent implantation in an overlap configuration in porcine coronary arteries. Inflammation was significantly reduced in the AC-SES compared to the BMS at both 30 and 90 days after implantation. Biocompatible, rapidly absorbable stent coatings enable the matching of drug release with coating erosion and provide for the controlled migration of coating material into tissue to reduce vicissitudes in drug tissue levels, optimizing efficacy and reducing potential toxicity. (C) 2012 Elsevier B. V. All rights reserved.
引用
收藏
页码:561 / 567
页数:7
相关论文
共 50 条
  • [21] Computational models for the in silico analysis of drug delivery from drug-eluting stents
    Gagliardi, Mariacristina
    THERAPEUTIC DELIVERY, 2011, 2 (01) : 1 - 3
  • [22] Present and future of endovascular SFA treatment: stents, stent-grafts, drug coated balloons and drug coated stents
    Bosiers, M.
    Deloose, K.
    Verbist, J.
    Peeters, P.
    JOURNAL OF CARDIOVASCULAR SURGERY, 2008, 49 (02): : 159 - 165
  • [23] Hyperbranched Polymer-Drug Conjugates with High Drug Payload for Enhanced Cellular Delivery
    Parag Kolhe
    Jayant Khandare
    Omathanu Pillai
    Sujatha Kannan
    Mary Lieh-Lai
    Rangaramanujam Kannan
    Pharmaceutical Research, 2004, 21 : 2185 - 2195
  • [24] Hydrogen bonding enhanced drug-polymer interaction for efficient drug loading and delivery
    Qu, Xiaotian
    Li, Junran
    Yu, Yishu
    Yang, Jie
    SOFT MATTER, 2024, 20 (16) : 3387 - 3391
  • [25] Hyperbranched polymer-drug conjugates with high drug payload for enhanced cellular delivery
    Kolhe, P
    Khandare, J
    Pillai, O
    Kannan, S
    Lieh-Lai, M
    Kannan, R
    PHARMACEUTICAL RESEARCH, 2004, 21 (12) : 2185 - 2195
  • [26] Drug release from xyloglucan beads coated with Eudragit for oral drug delivery
    Mi Kyong Yoo
    Hoo Kyun Choi
    Tae Hee Kim
    Yun Jaie Choi
    Toshihiro Akaike
    Mayumi Shirakawa
    Chong Su Cho
    Archives of Pharmacal Research, 2005, 28 : 736 - 742
  • [27] Drug release from xyloglucan beads coated with Eudragit for oral drug delivery
    Yoo, MK
    Choi, HK
    Kim, TH
    Choi, YJ
    Akaike, T
    Shirakawa, M
    Cho, CS
    ARCHIVES OF PHARMACAL RESEARCH, 2005, 28 (06) : 736 - 742
  • [28] Vinyl polymer-coated lorazepam particles for drug delivery to the airways
    Traynor, Matthew J.
    Zhao, Yanjun
    Brown, Marc B.
    Jones, Stuart A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 410 (1-2) : 9 - 16
  • [29] Multifunctional Polymer-Coated Carbon Nanotubes for Safe Drug Delivery
    Moore, Thomas L.
    Pitzer, Joshua E.
    Podila, Ramakrishna
    Wang, Xiaojia
    Lewis, Robert L.
    Grimes, Stuart W.
    Wilson, James R.
    Skjervold, Even
    Brown, Jared M.
    Rao, Apparao
    Alexis, Frank
    PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION, 2013, 30 (04) : 365 - 373
  • [30] Polymer coated mesoporous ceramic for drug delivery in bone tissue engineering
    Subhapradha, N.
    Abudhahir, Mohamed
    Aathira, A.
    Srinivasan, N.
    Moorthi, A.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 110 : 65 - 73